BIO EBITDA Margin
Bio-Rad Laboratories, Inc. Class A Common Stock · EBITDA Margin

BIO EBITDA Margin
Latest reported19.88%period ending
BIO EBITDA Margin (10.46% → 19.88%)
Annual ebitda margin
High-resolution chart · PNG
BIO ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 46.8373% | |
| -83.46% | |
| -24.5128% | |
| -161.6152% | |
| 191.2103% | |
| 199.4978% | |
| 104.6304% | |
| 29.4624% | |
| 12.4768% | |
| 9.9799% | |
| 14.8229% | |
| 13.9578% | |
| 15.0446% | |
| 19.8827% | |
| 20.2545% | |
| 20.388% | |
| 18.7506% | |
| 15.4195% | |
| 15.0405% | |
| 18.0073% | |
| 14.928% | |
| 15.8756% | |
| 18.8794% | |
| 20.1786% | |
| 18.7553% | |
| 15.1644% | |
| 13.8479% | |
| 11.7945% | |
| 10.7988% | |
| 13.5864% | |
| 14.2209% | |
| 15.0577% | |
| 8.2167% | |
| 8.5982% | |
| 11.0074% | |
| 12.1032% | |
| 12.2725% | |
| 13.1724% | |
| 13.4796% | |
| 12.0063% | |
| 10.4594% |